LTRN vs MAIA

Lantern Pharma Inc. vs MAIA Biotechnology, Inc. — Valuation Comparison 2026

LTRN

Pharmaceutical Preparations
Lantern Pharma Inc.
Quality
4.5
out of 10
Value Trap
24
SAFE
Price
$3.59
Last close
Models
7/13
Active
VS

MAIA

Pharmaceutical Preparations
MAIA Biotechnology, Inc.
Quality
4.5
out of 10
Value Trap
24
SAFE
Price
$1.39
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType LTRN Fair ValueLTRN Upside MAIA Fair ValueMAIA Upside
Bayesian DCF Intrinsic $1.04 -70.9% $0.64 -53.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.08 -96.1% $0.28 -79.7%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for LTRN vs MAIA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LTRN vs MAIA — Which Stock Is More Undervalued?

MAIA scores higher with a 4.5/10 quality rating vs LTRN's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lantern Pharma Inc. (LTRN) and MAIA Biotechnology, Inc. (MAIA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LTRN currently trades at $3.59 with a QOC of 4.5/10, while MAIA trades at $1.39 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).